In Q2 2026, Sharps Technology transitioned from marketing and distributing medical syringes to developing a blockchain and AI-powered finance platform targeting underbanked populations in Asia, Latin America, and Africa. The company’s new model relies heavily on a digital asset treasury dominated by Solana (SOL), staking rewards, and usage of stablecoin rails to provide dollar-denominated financial services. While this positions Sharps within a fast-growing fintech sub-sector, the pivot carries substantial operational and regulatory risks related to AI integration, digital asset concentration, and untested market adoption. Financially, the company maintains a strong liquidity position but continues to operate at a significant net loss stemming from the transformation costs.